从跟跑到超越！半岛医疗三类证产品问世，国产医美设备开启全球竞争新篇

Core Viewpoint - The article highlights the launch of two significant products by the company, namely the Peninsula Super Cannon and the Peninsula Counterclockwise, which represent advancements in domestic medical aesthetic equipment and aim to lead the industry towards standardization and global competitiveness [1][3][18]. Product Launch - The Peninsula Super Cannon is the first ultrasound skin treatment device to receive a Class III medical device registration certificate from the National Medical Products Administration (NMPA) [1]. - The Peninsula Counterclockwise is the first domestic Class III radiofrequency skin treatment device to obtain both NMPA and FDA certifications [1]. Technological Advancements - Both products are the result of years of technological innovation and rigorous clinical trials, with the Super Cannon showing an efficacy rate of over 82% in improving skin laxity and a satisfaction rate exceeding 88% three months post-treatment [5]. - The Counterclockwise demonstrated a scar improvement efficacy rate of over 96% and a satisfaction rate close to 98% three months after treatment [7]. Industry Impact - The introduction of these products is seen as a step towards standardizing the medical aesthetic equipment industry in China, which has historically been dominated by international players [11][12]. - The company has been proactive in establishing clinical standards and training programs, having trained over 9,000 certified ultrasound physicians and 3,000 certified Counterclockwise physicians [9]. Market Position - The company has positioned itself among the top six global energy source medical aesthetic equipment manufacturers, with its products sold in over 70 countries and regions [18]. - The emergence of the Super Cannon and Counterclockwise signifies a shift in the domestic market from low-end competition to high-end innovation, marking China's entry into the global competitive landscape [20]. Research and Development - The company invests over 25% of its revenue annually into research and development, employing a team of nearly 400 researchers, which constitutes about 30% of its total workforce [16]. - The company has applied for over 1,000 domestic and international patents, with more than 400 granted, establishing a strong technological moat [16].